Anti_Human, mab CXCL13 Source Mouse
- Known as:
- Anti_Human, mab CXCL13 Source Mouse
- Catalog number:
- 101-M351
- Product Quantity:
- 100 µg
- Category:
- -
- Supplier:
- Reliatech
- Gene target:
- Anti_Human mab CXCL13 Source Mouse
Related genes to: Anti_Human, mab CXCL13 Source Mouse
- Gene:
- CXCL13 NIH gene
- Name:
- C-X-C motif chemokine ligand 13
- Previous symbol:
- SCYB13
- Synonyms:
- BLC, BCA-1, BLR1L, ANGIE, ANGIE2
- Chromosome:
- 4q21.1
- Locus Type:
- gene with protein product
- Date approved:
- 2000-09-05
- Date modifiied:
- 2016-10-05
Related products to: Anti_Human, mab CXCL13 Source Mouse
Related articles to: Anti_Human, mab CXCL13 Source Mouse
- Testicular aging is a key driver of declining male reproductive health, but a comprehensive understanding of its underlying epigenetic drivers is lacking. To address this, we construct a multiomics aging atlas by integrating single-cell RNA sequencing, single-cell assay for transposase-accessible chromatin sequencing (scATAC-seq), and spatial transcriptomics of young and aged mouse testes. Our analysis reveals that altered chromatin accessibility accompanies transcriptional dysregulation and identifies spermatogonial stem cells (SSCs) as the most epigenetically vulnerable population. We further pinpoint ZFX as a consistently downregulated transcription factor in early germ cells, linking its decline to compromised SSC maintenance. In the somatic niche, we define disrupted regulatory networks that underpin impaired blood-testis barrier integrity in Sertoli cells and steroidogenic dysfunction in Leydig cells. Notably, we uncover an aberrant expansion of CD206H2-Eb1 macrophages that propagates local inflammation via the secreted factor CXCL13, which we demonstrate is sufficient to disrupt the SSC niche. Cross-species analysis identifies conserved aging-associated regulons, including BRCA1 and E2F1. This work provides a resource for understanding testicular senescence and nominates ZFX and CXCL13 as potential therapeutic targets for mitigating age-related reproductive decline. - Source: PubMed
Publication date: 2026/05/20
Lin NanheZhang ZhiqiangSha XianshenYao JiahuiSun XiangzhouSun RuiYang JiajiaYu QiuhuaWu ZhengfengGuan JianfengMo ChengqiangOuyang BinXie Yun - Pediatric Lyme neuroborreliosis (LNB), caused by Borrelia burgdorferi sensu lato (Bbsl), may rarely present with cerebrovascular involvement, particularly affecting the posterior circulation and causing ischemic or hemorrhagic stroke. In endemic regions, LNB should be considered a potential cause of pediatric stroke. - Source: PubMed
Publication date: 2026/05/21
Pöyhönen HeidiPietikäinen AnnukkaRinne VarpuSirén AapoRanne SatuPeltola VilleHytönen Jukka - Immunotherapy (IO) has improved prognosis of non-small cell lung cancer (NSCLC); however, some patients experience primary IO resistance (PIR). CXCL13 could be a promising PIR biomarker due to its role in antitumor immune responses. - Source: PubMed
Publication date: 2026/05/21
Molina-Alejandre MartaMartínez-Toledo CristinaSierra-Rodero BelénCalvo VirginiaCollazo-Lorduy AnaDiz-Tain PilarSequero-Lopez SilviaVázquez Estévez SergioMielgo XabierMartinez-Banaclocha NatividadGonzález-Larriba Jose LuísSánchez-Hernández AlfredoEstival AnnaCoves Sarto JuanNadal ErnestBernabé ReyesPonce-Aix SantiagoGarcía-Grande AránzazuMedina-Valdivieso SoledadMañas-Mora ElisaMoreno-Alonso ElenaGil-González ÁngelesGutiérrez-Escobedo Juan ManuelPeña-Cabia SilviaMegías DiegoBlanco MariolaCruz-Bermúdez AlbertoProvencio Mariano - Sensory innervation regulates lung physiology and pathology, but its role in lung cancer is poorly understood. We show that lung adenocarcinoma (LUAD) progression locally amplifies nociceptive sensory innervation and activation, which drives the release of a major sensory neuropeptide, calcitonin gene-related peptide (CGRP). CGRP acts on a subset of macrophages, thereby impairing the recruitment of CXCL13 fibroblasts and blocking tertiary lymphoid structure (TLS) assembly, a key predictor of LUAD prognosis. Local sensory denervation restores TLS formation, enhances B and T cell-dependent immunity, and suppresses tumor growth. Cigarette smoke extract (CSE) further activates this neural circuit to accelerate LUAD progression. In CSE-exposed animals, pharmacologic CGRP blockade sensitizes tumors to immunotherapy and prolongs survival. Together, our findings uncover a neuroimmune axis linking nociceptive neurons, TLS, and LUAD and identify neurogenic inflammation as a mechanism by which smoking promotes lung tumorigenesis independent of somatic mutagenesis. - Source: PubMed
Publication date: 2026/05/19
Ho Ya-HsuanBregni GiacomoStazi MarcoPeinado PaolaChen Pei-HsingBallabio ClaudioBoulat VictoireVadera ShreeGuan YilinLiu ZhikaiAlonso de la Vega AliciaWang LiHo Chao-ChiVeiga-Fernandes HenriqueDownward JulianHsieh Min-ShuKopanitsa Maksym VKassiotis GeorgeTsantoulas ChristoforosSchappe Michael SMargineanu Michael-BogdanCalado Dinis PedroChiu Isaac MSwanton CharlesChen Jin-ShingLi Leanne - Immune checkpoint blockade (ICB) has improved outcomes for a subset of colorectal cancer (CRC) patients, yet the cellular determinants that drive heterogeneous treatment responses remain insufficiently understood. The extent to which ICB reshapes immune populations across tumor, blood, and adjacent normal tissues at single-cell resolution is largely unexplored. - Source: PubMed
Publication date: 2026/05/04
Zhao HengWu GaoZhao JunhongWang QianwenCheng WenkangLi JieYang Jin